Please login to the form below

Not currently logged in
Email:
Password:

Research and Development

This page shows the latest Research and Development news and features for those working in and with pharma, biotech and healthcare.

Digital Trials

Digital Trials

The pharmaceutical industry spent over four times more on research and development in 2015 than in 1995, with no corresponding increase in the number of drugs approved by the Food and ... Summary. Declining research and development (R&D) efficiency is

Latest news

  • Safety first: AI adoption in the healthcare sector Safety first: AI adoption in the healthcare sector

    the healthcare system is likely to be profound”– through more efficient research and development, the adoption of better methods of healthcare delivery and more informed clinical decision- making. ... Ethical conduct. Companies should develop their

  • Shire’s angioedema drug Takhzyro recommended in Europe Shire’s angioedema drug Takhzyro recommended in Europe

    Andreas Busch, executive vice president, head of research and development at Shire. ... We are excited about the future potential of lanadelumab in helping to address the needs of those living with this chronic and unpredictable disease.”.

  • UK science could be 'crippled' by a hard Brexit UK science could be 'crippled' by a hard Brexit

    Nurse added: Science and research matter for the UK’s economic growth, for the nation’s health and quality of life, and for the environment. ... UK science minister Sam Gyimah. This plan concerns “unprecedented amounts of money”going into

  • New Pfizer boss shakes up leadership team New Pfizer boss shakes up leadership team

    Current global president, worldwide research and development and medical, Mikael Dolsten, will also become chief medical officer. ... John Young, group president, chief business officer will also assume new responsibilities, which will see him focus on

  • Daiichi-Sankyo takes rival to Roche’s Kadcyla into phase 3 Daiichi-Sankyo takes rival to Roche’s Kadcyla into phase 3

    drug. Daiichi Sankyo's Gilles Gallant. “The DESTINY-Breast03 trial is a key element of our comprehensive development strategy to determine the potential of [fam-] trastuzumab deruxtecan as a second-line ... therapy in patients with HER2 positive

More from news
Approximately 10 fully matching, plus 699 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Current global president, worldwide research and development and medical, Mikael Dolsten, will also become chief medical officer. ... John Young, group president and chief business officer, will also assume new responsibilities, which will see him focus

  • Redefining communications excellence Redefining communications excellence

    These research efforts are guided by more data than ever but there are downsides to abundance, particularly when designing disease-specific campaigns that target patients and the general public. ... Measuring success. Audience research, message

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    AstraZeneca’s global HQ and Research &Development Centre will house approximately 2, 000 employees, and has been designed specifically to encourage interdisciplinary working with scientists engaged on small molecules, large molecules ... This physical

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    with the State Development Investment Corporation (SDIC) to set up Dizal Pharma, a joint venture dedicated to the research and development of new medicines. ... Growing confidence in China as an R&D centre. While some companies have pared back their

  • Advancing women in healthcare Advancing women in healthcare

    Then I developed the courage to take a crazy idea and run with it.”. ... Professor Melissa Hanna-Brown is Associate Research Fellow at Pfizer UK. Her job involves helping Pfizer’s research and development teams adopt new technology – something

More from intelligence
Approximately 0 fully matching, plus 86 partially matching documents found.

Latest appointments

  • Industry round up: appointments Industry round up: appointments

    Meanwhile, Silence Therapeutics has also bolstered its leadership team with the addition of Richard Jenkins, who joins the group following 28 years’experience in clinical development and drug discovery. ... He joins Concept from Eurofins, where he was

  • Axovant poaches Allergan’s and Teva’s chief medical and science officers Axovant poaches Allergan’s and Teva’s chief medical and science officers

    Gavin Corcoran and Michael Hayden join the biopharma. Clinical stage biopharmaceutical group Axovant has appointed Gavin Corcoran as its new executive vice president of research and development. ... Prior to his time at Teva as its president of global

  • Kevin Sin joins GSK Kevin Sin joins GSK

    Kevin Sin has joined GlaxoSmithKline as its senior vice president, head of worldwide business development for pharmaceutical research and development. ... years. Dr Hal Barron, chief scientific officer and president of research and development, GSK, said:

  • Redx poaches AstraZeneca senior executive Redx poaches AstraZeneca senior executive

    Drug discovery and development group Redx Pharma has appointed its new chief executive officer in the form of Lisa Anson. ... oncology, and vice president of emerging brands, working closely with the research and development teams.

  • Metrion Biosciences adds to its board Metrion Biosciences adds to its board

    Metrion Biosciences, the specialist ion channel contract research and drug discovery group, has appointed Dr Barry Kenny and Dr Andrew Southan to its board of directors, a move that will see ... He has over 25 years’experience in ion channel research

More from appointments
Approximately 0 fully matching, plus 159 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics